XBiotech (XBIT) Price to Book (2015 - 2026)

XBiotech has reported Price to Book for 12 years, with the latest figure at 0.55 in Q2 2026.

• On a quarterly basis, Price to Book rose 4.33% year-over-year to 0.55 in Q2 2026; TTM through Jun 2026 was 0.55, a 4.33% increase from a year earlier, with the FY2025 full-year figure at 0.52, down 21.42% from the prior year.
• Price to Book was 0.55 for Q2 2026 at XBiotech, up from 0.52 in the prior quarter.
• The five-year high for Price to Book was 1.23 in Q3 2024, with the low at 0.44 in Q1 2023.
• Average Price to Book over 5 years is 0.67, with a median of 0.56 recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Price to Book slumped 68.65% in 2022, then soared 166.86% in 2024.
• Over 5 years, Price to Book stood at 0.44 in 2022, then gained by 25.18% to 0.56 in 2023, then gained by 18.77% to 0.66 in 2024, then decreased by 21.42% to 0.52 in 2025, then grew by 5.14% to 0.55 in 2026.
• The last three Price to Book figures came in at 0.55 (Q2 2026), 0.52 (Q4 2025), and 0.49 (Q3 2025), per Business Quant data.